aluates Reports

$ 0.0

Automative

Recombinant Factor VIII - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-11A12357

Global Recombinant Factor VIII Industry Research Report Growth Trends and Competitive Analysis 2022 2028

BUY CHAPTERS

Recombinant Factor VIII - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-11A12357

Report

September 2024

Pages:100

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Takeda

Bayer

CSL Limited

Pfizer Inc

Biogen

Octapharma AG

NovoNordisk

Recombinant Factor VIII - Market Size

The global market for Recombinant Factor VIII was estimated to be worth US$ 1652 million in 2023 and is forecast to a readjusted size of US$ 2310.5 million by 2030 with a CAGR of 4.9% during the forecast period 2024-2030

Recombinant Factor VIII - Market

RECOMBINATE is recombinant Factor VIII, a clotting factor that is deficient in people with hemophilia A.

The market for recombinant antihemophilic factor has witnessed significant growth in recent years. This can be attributed to several factors, including the increasing prevalence of hemophilia, advancements in recombinant DNA technology, and improved access to healthcare services. Hemophilia is a genetic bleeding disorder that requires lifelong treatment with antihemophilic factors, such as factor VIII or factor IX. Recombinant antihemophilic factor, produced using recombinant DNA technology, offers advantages over plasma-derived products, including enhanced safety, reduced risk of infection transmission, and increased supply stability.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant Factor VIII, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Recombinant Factor VIII by region & country, by Type, and by Application.

The Recombinant Factor VIII market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Factor VIII.

Market Segmentation

Scope of Recombinant Factor VIII - Market Report

Report Metric	Details
Report Name	Recombinant Factor VIII - Market
Forecasted market size in 2030	US$ 2310.5 million
CAGR	4.9%
Forecasted years	2024 - 2030
Segment by Type:	200IU 250IU
Segment by Application	Hospital Pharmacy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Takeda, Bayer, CSL, Pfizer, Biogen, Octapharma, NovoNordisk
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Recombinant Factor VIII manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Recombinant Factor VIII in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Recombinant Factor VIII in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Recombinant Factor VIII - Market size in 2030?

Ans: The Recombinant Factor VIII - Market size in 2030 will be US$ 2310.5 million.

Who are the main players in the Recombinant Factor VIII - Market report?

Ans: The main players in the Recombinant Factor VIII - Market are Takeda, Bayer, CSL, Pfizer, Biogen, Octapharma, NovoNordisk

What are the Application segmentation covered in the Recombinant Factor VIII - Market report?

Ans: The Applications covered in the Recombinant Factor VIII - Market report are Hospital, Pharmacy

What are the Type segmentation covered in the Recombinant Factor VIII - Market report?

Ans: The Types covered in the Recombinant Factor VIII - Market report are 200IU, 250IU

1 Market Overview

1.1 Recombinant Factor VIII Product Introduction

1.2 Global Recombinant Factor VIII Market Size Forecast

1.2.1 Global Recombinant Factor VIII Sales Value (2019-2030)

1.2.2 Global Recombinant Factor VIII Sales Volume (2019-2030)

1.2.3 Global Recombinant Factor VIII Sales Price (2019-2030)

1.3 Recombinant Factor VIII Market Trends & Drivers

1.3.1 Recombinant Factor VIII Industry Trends

1.3.2 Recombinant Factor VIII Market Drivers & Opportunity

1.3.3 Recombinant Factor VIII Market Challenges

1.3.4 Recombinant Factor VIII Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Recombinant Factor VIII Players Revenue Ranking (2023)

2.2 Global Recombinant Factor VIII Revenue by Company (2019-2024)

2.3 Global Recombinant Factor VIII Players Sales Volume Ranking (2023)

2.4 Global Recombinant Factor VIII Sales Volume by Company Players (2019-2024)

2.5 Global Recombinant Factor VIII Average Price by Company (2019-2024)

2.6 Key Manufacturers Recombinant Factor VIII Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Recombinant Factor VIII Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Recombinant Factor VIII

2.9 Recombinant Factor VIII Market Competitive Analysis

2.9.1 Recombinant Factor VIII Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Recombinant Factor VIII Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Factor VIII as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 200IU

3.1.2 250IU

3.2 Global Recombinant Factor VIII Sales Value by Type

3.2.1 Global Recombinant Factor VIII Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Recombinant Factor VIII Sales Value, by Type (2019-2030)

3.2.3 Global Recombinant Factor VIII Sales Value, by Type (%) (2019-2030)

3.3 Global Recombinant Factor VIII Sales Volume by Type

3.3.1 Global Recombinant Factor VIII Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Recombinant Factor VIII Sales Volume, by Type (2019-2030)

3.3.3 Global Recombinant Factor VIII Sales Volume, by Type (%) (2019-2030)

3.4 Global Recombinant Factor VIII Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Pharmacy

4.2 Global Recombinant Factor VIII Sales Value by Application

4.2.1 Global Recombinant Factor VIII Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Recombinant Factor VIII Sales Value, by Application (2019-2030)

4.2.3 Global Recombinant Factor VIII Sales Value, by Application (%) (2019-2030)

4.3 Global Recombinant Factor VIII Sales Volume by Application

4.3.1 Global Recombinant Factor VIII Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Recombinant Factor VIII Sales Volume, by Application (2019-2030)

4.3.3 Global Recombinant Factor VIII Sales Volume, by Application (%) (2019-2030)

4.4 Global Recombinant Factor VIII Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Recombinant Factor VIII Sales Value by Region

5.1.1 Global Recombinant Factor VIII Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Recombinant Factor VIII Sales Value by Region (2019-2024)

5.1.3 Global Recombinant Factor VIII Sales Value by Region (2025-2030)

5.1.4 Global Recombinant Factor VIII Sales Value by Region (%), (2019-2030)

5.2 Global Recombinant Factor VIII Sales Volume by Region

5.2.1 Global Recombinant Factor VIII Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Recombinant Factor VIII Sales Volume by Region (2019-2024)

5.2.3 Global Recombinant Factor VIII Sales Volume by Region (2025-2030)

5.2.4 Global Recombinant Factor VIII Sales Volume by Region (%), (2019-2030)

5.3 Global Recombinant Factor VIII Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Recombinant Factor VIII Sales Value, 2019-2030

5.4.2 North America Recombinant Factor VIII Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Recombinant Factor VIII Sales Value, 2019-2030

5.5.2 Europe Recombinant Factor VIII Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Recombinant Factor VIII Sales Value, 2019-2030

5.6.2 Asia Pacific Recombinant Factor VIII Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Recombinant Factor VIII Sales Value, 2019-2030

5.7.2 South America Recombinant Factor VIII Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Recombinant Factor VIII Sales Value, 2019-2030

5.8.2 Middle East & Africa Recombinant Factor VIII Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Recombinant Factor VIII Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Recombinant Factor VIII Sales Value

6.2.1 Key Countries/Regions Recombinant Factor VIII Sales Value, 2019-2030

6.2.2 Key Countries/Regions Recombinant Factor VIII Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Recombinant Factor VIII Sales Value, 2019-2030

6.3.2 United States Recombinant Factor VIII Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Recombinant Factor VIII Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Recombinant Factor VIII Sales Value, 2019-2030

6.4.2 Europe Recombinant Factor VIII Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Recombinant Factor VIII Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Recombinant Factor VIII Sales Value, 2019-2030

6.5.2 China Recombinant Factor VIII Sales Value by Type (%), 2023 VS 2030

6.5.3 China Recombinant Factor VIII Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Recombinant Factor VIII Sales Value, 2019-2030

6.6.2 Japan Recombinant Factor VIII Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Recombinant Factor VIII Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Recombinant Factor VIII Sales Value, 2019-2030

6.7.2 South Korea Recombinant Factor VIII Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Recombinant Factor VIII Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Recombinant Factor VIII Sales Value, 2019-2030

6.8.2 Southeast Asia Recombinant Factor VIII Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Recombinant Factor VIII Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Recombinant Factor VIII Sales Value, 2019-2030

6.9.2 India Recombinant Factor VIII Sales Value by Type (%), 2023 VS 2030

6.9.3 India Recombinant Factor VIII Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Takeda

7.1.1 Takeda Company Information

7.1.2 Takeda Introduction and Business Overview

7.1.3 Takeda Recombinant Factor VIII Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Takeda Recombinant Factor VIII Product Offerings

7.1.5 Takeda Recent Development

7.2 Bayer

7.2.1 Bayer Company Information

7.2.2 Bayer Introduction and Business Overview

7.2.3 Bayer Recombinant Factor VIII Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Bayer Recombinant Factor VIII Product Offerings

7.2.5 Bayer Recent Development

7.3 CSL

7.3.1 CSL Company Information

7.3.2 CSL Introduction and Business Overview

7.3.3 CSL Recombinant Factor VIII Sales, Revenue and Gross Margin (2019-2024)

7.3.4 CSL Recombinant Factor VIII Product Offerings

7.3.5 CSL Recent Development

7.4 Pfizer

7.4.1 Pfizer Company Information

7.4.2 Pfizer Introduction and Business Overview

7.4.3 Pfizer Recombinant Factor VIII Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Pfizer Recombinant Factor VIII Product Offerings

7.4.5 Pfizer Recent Development

7.5 Biogen

7.5.1 Biogen Company Information

7.5.2 Biogen Introduction and Business Overview

7.5.3 Biogen Recombinant Factor VIII Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Biogen Recombinant Factor VIII Product Offerings

7.5.5 Biogen Recent Development

7.6 Octapharma

7.6.1 Octapharma Company Information

7.6.2 Octapharma Introduction and Business Overview

7.6.3 Octapharma Recombinant Factor VIII Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Octapharma Recombinant Factor VIII Product Offerings

7.6.5 Octapharma Recent Development

7.7 NovoNordisk

7.7.1 NovoNordisk Company Information

7.7.2 NovoNordisk Introduction and Business Overview

7.7.3 NovoNordisk Recombinant Factor VIII Sales, Revenue and Gross Margin (2019-2024)

7.7.4 NovoNordisk Recombinant Factor VIII Product Offerings

7.7.5 NovoNordisk Recent Development

8 Industry Chain Analysis

8.1 Recombinant Factor VIII Industrial Chain

8.2 Recombinant Factor VIII Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Recombinant Factor VIII Sales Model

8.5.2 Sales Channel

8.5.3 Recombinant Factor VIII Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Takeda

Bayer

CSL Limited

Pfizer Inc

Biogen

Octapharma AG

NovoNordisk

List of Tables

Table 1. Recombinant Factor VIII Market Trends

Table 2. Recombinant Factor VIII Market Drivers & Opportunity

Table 3. Recombinant Factor VIII Market Challenges

Table 4. Recombinant Factor VIII Market Restraints

Table 5. Global Recombinant Factor VIII Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Recombinant Factor VIII Revenue Market Share by Company (2019-2024)

Table 7. Global Recombinant Factor VIII Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Recombinant Factor VIII Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Recombinant Factor VIII Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Recombinant Factor VIII Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Recombinant Factor VIII Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Recombinant Factor VIII

Table 13. Global Recombinant Factor VIII Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Factor VIII as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Recombinant Factor VIII Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Recombinant Factor VIII Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Recombinant Factor VIII Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Recombinant Factor VIII Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Recombinant Factor VIII Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Recombinant Factor VIII Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Recombinant Factor VIII Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Recombinant Factor VIII Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Recombinant Factor VIII Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Recombinant Factor VIII Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Recombinant Factor VIII Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Recombinant Factor VIII Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Recombinant Factor VIII Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Recombinant Factor VIII Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Recombinant Factor VIII Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Recombinant Factor VIII Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Recombinant Factor VIII Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Recombinant Factor VIII Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Recombinant Factor VIII Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Recombinant Factor VIII Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Recombinant Factor VIII Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Recombinant Factor VIII Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Recombinant Factor VIII Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Recombinant Factor VIII Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Recombinant Factor VIII Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Recombinant Factor VIII Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Recombinant Factor VIII Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Recombinant Factor VIII Sales Value by Region (2019-2024) & (%)

Table 44. Global Recombinant Factor VIII Sales Value by Region (2025-2030) & (%)

Table 45. Global Recombinant Factor VIII Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Recombinant Factor VIII Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Recombinant Factor VIII Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Recombinant Factor VIII Sales Volume by Region (2019-2024) & (%)

Table 49. Global Recombinant Factor VIII Sales Volume by Region (2025-2030) & (%)

Table 50. Global Recombinant Factor VIII Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Recombinant Factor VIII Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Recombinant Factor VIII Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Recombinant Factor VIII Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Recombinant Factor VIII Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Recombinant Factor VIII Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Recombinant Factor VIII Sales Volume, (2025-2030) & (K Units)

Table 57. Takeda Company Information

Table 58. Takeda Introduction and Business Overview

Table 59. Takeda Recombinant Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Takeda Recombinant Factor VIII Product Offerings

Table 61. Takeda Recent Development

Table 62. Bayer Company Information

Table 63. Bayer Introduction and Business Overview

Table 64. Bayer Recombinant Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. Bayer Recombinant Factor VIII Product Offerings

Table 66. Bayer Recent Development

Table 67. CSL Company Information

Table 68. CSL Introduction and Business Overview

Table 69. CSL Recombinant Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. CSL Recombinant Factor VIII Product Offerings

Table 71. CSL Recent Development

Table 72. Pfizer Company Information

Table 73. Pfizer Introduction and Business Overview

Table 74. Pfizer Recombinant Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. Pfizer Recombinant Factor VIII Product Offerings

Table 76. Pfizer Recent Development

Table 77. Biogen Company Information

Table 78. Biogen Introduction and Business Overview

Table 79. Biogen Recombinant Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. Biogen Recombinant Factor VIII Product Offerings

Table 81. Biogen Recent Development

Table 82. Octapharma Company Information

Table 83. Octapharma Introduction and Business Overview

Table 84. Octapharma Recombinant Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 85. Octapharma Recombinant Factor VIII Product Offerings

Table 86. Octapharma Recent Development

Table 87. NovoNordisk Company Information

Table 88. NovoNordisk Introduction and Business Overview

Table 89. NovoNordisk Recombinant Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 90. NovoNordisk Recombinant Factor VIII Product Offerings

Table 91. NovoNordisk Recent Development

Table 92. Key Raw Materials Lists

Table 93. Raw Materials Key Suppliers Lists

Table 94. Recombinant Factor VIII Downstream Customers

Table 95. Recombinant Factor VIII Distributors List

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

List of Figures

Figure 1. Recombinant Factor VIII Product Picture

Figure 2. Global Recombinant Factor VIII Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Recombinant Factor VIII Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Recombinant Factor VIII Sales Volume (2019-2030) & (K Units)

Figure 5. Global Recombinant Factor VIII Sales Price (2019-2030) & (USD/Unit)

Figure 6. Recombinant Factor VIII Report Years Considered

Figure 7. Global Recombinant Factor VIII Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Recombinant Factor VIII Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Recombinant Factor VIII Revenue in 2023

Figure 10. Recombinant Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. 200IU Picture

Figure 12. 250IU Picture

Figure 13. Global Recombinant Factor VIII Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Recombinant Factor VIII Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Recombinant Factor VIII Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Recombinant Factor VIII Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Recombinant Factor VIII Price by Type (2019-2030) & (USD/Unit)

Figure 18. Product Picture of Hospital

Figure 19. Product Picture of Pharmacy

Figure 20. Global Recombinant Factor VIII Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Recombinant Factor VIII Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Recombinant Factor VIII Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 23. Global Recombinant Factor VIII Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Recombinant Factor VIII Price by Application (2019-2030) & (USD/Unit)

Figure 25. North America Recombinant Factor VIII Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Recombinant Factor VIII Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Recombinant Factor VIII Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Recombinant Factor VIII Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Recombinant Factor VIII Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Recombinant Factor VIII Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Recombinant Factor VIII Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Recombinant Factor VIII Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Recombinant Factor VIII Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Recombinant Factor VIII Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Recombinant Factor VIII Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Recombinant Factor VIII Sales Volume (%), (2019-2030)

Figure 37. United States Recombinant Factor VIII Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Recombinant Factor VIII Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Recombinant Factor VIII Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Recombinant Factor VIII Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Recombinant Factor VIII Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Recombinant Factor VIII Sales Value by Application (%), 2023 VS 2030

Figure 43. China Recombinant Factor VIII Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Recombinant Factor VIII Sales Value by Type (%), 2023 VS 2030

Figure 45. China Recombinant Factor VIII Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Recombinant Factor VIII Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Recombinant Factor VIII Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Recombinant Factor VIII Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Recombinant Factor VIII Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Recombinant Factor VIII Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Recombinant Factor VIII Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Recombinant Factor VIII Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Recombinant Factor VIII Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Recombinant Factor VIII Sales Value by Application (%), 2023 VS 2030

Figure 55. India Recombinant Factor VIII Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Recombinant Factor VIII Sales Value by Type (%), 2023 VS 2030

Figure 57. India Recombinant Factor VIII Sales Value by Application (%), 2023 VS 2030

Figure 58. Recombinant Factor VIII Industrial Chain

Figure 59. Recombinant Factor VIII Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Recombinant Antihemophilic Factor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Recombinant Coagulation Factor Ⅷ for Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Recombinant Human Coagulation Factor VIII for Injection Market Research Report 2024

Hemophilia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antihemophilic Factor Recombinant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Recombinant Coagulation Factor Concentrate Market Research Report 2024

Global Recombinant Activated Coagulation Factor VII Market Research Report 2025

Global Recombinant Antihemophilic Globulin Market Research Report 2024

Rare Hemophilia Factors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Human Factor VIII Concentrate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Recombinant Coagulation Factors Market Insights Forecast to 2030

Global Human Coagulation Factor VIII Market Research Report 2020

Coagulation Factors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antihemophilic Factor Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Haemophilia Treatment Market Insights Forecast to 2030

Cryoprecipitated Antihemophilic Factor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Recombinant Coagulation Factor IX Market Research Report 2025

Factor VIII Deficiency Treatment Market

Human Coagulation Factor Ⅷ Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Organoid Dissociation Reagent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-36V19274

Wed May 21 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Grade Packaging Film Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-12I19427

Wed May 21 00:00:00 UTC 2025

Add to Cart

Global Animal Toxicity Test Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19O13409

Wed May 21 00:00:00 UTC 2025

Add to Cart

Global Commercial Scale-Up Facilities Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-36X13748

Wed May 21 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions